German Research Network On Schizophrenia Report issue

Academic/Hospital Phase 4
Founded: Germany (1999)

Organization Overview

First Clinical Trial
2000
NCT00157378
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mental Disorders (Phase 4)

Prodromal Symptoms (Phase 4)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4